These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24797915)

  • 1. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice.
    Holgersen K; Kvist PH; Hansen AK; Holm TL
    Int Immunopharmacol; 2014 Jul; 21(1):137-47. PubMed ID: 24797915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
    Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL
    J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
    Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis.
    Blum AM; Metwali A; Elliott DE; Berg DJ; Weinstock JV
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G320-5. PubMed ID: 15246967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
    Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
    J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice.
    Holgersen K; Dobie R; Farquharson C; vanʼt Hof R; Ahmed SF; Hansen AK; Holm TL
    Inflamm Bowel Dis; 2015 Feb; 21(2):257-66. PubMed ID: 25569742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
    Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
    J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam accelerates development of colitis in T-cell receptor alpha chain-deficient mice.
    Nishiyori A; Nagakura Y; Ichikawa K
    Eur J Pharmacol; 2009 Aug; 615(1-3):241-5. PubMed ID: 19446544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
    Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
    Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.
    Davidson NJ; Hudak SA; Lesley RE; Menon S; Leach MW; Rennick DM
    J Immunol; 1998 Sep; 161(6):3143-9. PubMed ID: 9743382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.
    Simpson SJ; Mizoguchi E; Allen D; Bhan AK; Terhorst C
    Eur J Immunol; 1995 Sep; 25(9):2618-25. PubMed ID: 7589135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
    Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
    Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
    Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Opioid Receptor Blockade Enhances Epithelial Damage in Piroxicam-Accelerated Colitis in IL-10-Deficient Mice.
    Mas-Orea X; Sebert M; Benamar M; Petitfils C; Blanpied C; Saoudi A; Deraison C; Barreau F; Cenac N; Dietrich G
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.
    Piccotti JR; Chan SY; Li K; Eichwald EJ; Bishop DK
    J Immunol; 1997 Jan; 158(2):643-8. PubMed ID: 8992979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
    Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
    Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.